Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in vitro fertilisation
K Lattes, M Brassesco, M Gomez… - Gynecological …, 2015 - Taylor & Francis
Poor ovarian response (POR) often means low success rates after in vitro fertilisation (IVF).
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …
Six‐week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: A self‐controlled …
MH Cai, XY Liang, YQ Wu, R Huang… - Journal of Obstetrics …, 2019 - Wiley Online Library
Aim The purpose was to explore whether the 6 weeks of growth hormone (GH) pretreatment
could increase the live birth rate of poor ovarian responders (POR). Methods This self …
could increase the live birth rate of poor ovarian responders (POR). Methods This self …
Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF
JL Yovich, JD Stanger - Reproductive biomedicine online, 2010 - Elsevier
In a sequential crossover study of IVF conducted from 2002 to 2006, growth hormone (GH)
supplementation was assessed in poor-prognosis patients, categorized on the basis of past …
supplementation was assessed in poor-prognosis patients, categorized on the basis of past …
[HTML][HTML] Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis
M Cozzolino, GN Cecchino, G Troiano, C Romanelli - Fertility and sterility, 2020 - Elsevier
Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …
Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study
SA Choe, MJ Kim, HJ Lee, J Kim, EM Chang… - Archives of Gynecology …, 2018 - Springer
Purpose Supplementation of growth hormone (GH) during controlled ovarian stimulation
(COS) has been suggested to improve ovarian response. Despite potential benefits in poor …
(COS) has been suggested to improve ovarian response. Despite potential benefits in poor …
The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials
P Yang, R Wu, H Zhang - Reproductive Biology and Endocrinology, 2020 - Springer
Purpose The aim of this meta-analysis was to evaluate the effect of growth hormone (GH)
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …
Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate
RJ Norman, H Alvino, LM Hull, BW Mol, RJ Hart… - Reproductive …, 2019 - Elsevier
Research question Does the addition of human growth hormone (HGH) to an IVF cycle
improve the live birth rate in previously documented poor responders to FSH? Design …
improve the live birth rate in previously documented poor responders to FSH? Design …
The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: randomized control trial
DMR Dakhly, YA Bassiouny, YA Bayoumi… - European Journal of …, 2018 - Elsevier
Objective to detect the impact of growth hormone (GH) co-treatment to the long down
regulation protocol, on the outcomes of IVF/ICSI cycles in poor responders. Study Design …
regulation protocol, on the outcomes of IVF/ICSI cycles in poor responders. Study Design …
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic …
XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - journals.lww.com
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
Use of growth hormone in the IVF treatment of women with poor ovarian reserve
RJ Hart - Frontiers in Endocrinology, 2019 - frontiersin.org
Growth hormone (GH) has been used as an adjunct in the field of female infertility treatment
for more than 25 years, although, apart from treating women with GH deficiency its role has …
for more than 25 years, although, apart from treating women with GH deficiency its role has …